Begin main content

New at CADTH — October 2019

Last updated: October 8, 2019
Product Line: New at CADTH
Result type: Report

News and Events

Dr. Brian O’Rourke has announced his intention to retire from CADTH, effective March 31, 2020. Dr. O’Rourke joined CADTH in January 2009 after a distinguished career as a pharmacist and health care executive with the Canadian military. Under his leadership, CADTH has grown significantly and is recognized internationally as one of the pre-eminent health technology assessment agencies in the world. Brian leaves a tremendous legacy at CADTH in many areas. Everyone at CADTH is incredibly grateful for his hard work and unwavering commitment. Congratulations Dr. O’Rourke on a job well done and a retirement well deserved. Learn more here.

CADTH is pleased to announce the 2020 CADTH Symposium Travel Award Program for students and patient group representatives. This year, eligible students and patient group representatives can receive up to $2,000 to offset registration, travel, food, accommodation, and other conference-related expenses. More details on this opportunity here.

CADTH is looking for volunteers to review abstracts submitted for presentation at the 2020 CADTH Symposium. This is a great way to participate in developing a stellar program that will feature relevant and engaging topics in a wide variety of formats: workshops, oral presentations, poster presentations, panel discussions, debates, and breakfast sessions. If you’re interested in joining the Abstract Review Committee, please register here.

CADTH will be hosting a webinar on November 5th, in collaboration with Continuing Education and Development for Nurses (CEDN), on the current evidence on Internet-delivered cognitive behavioral therapy (iCBT). This webinar will also include information on Saskatchewan’s Online Therapy Unit. Please register here.

Drug Reimbursement Recommendations

CADTH recently issued the following CADTH Canadian Drug Expert Committee (CDEC) drug reimbursement recommendations:

CADTH recently issued the following CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) drug reimbursement recommendations:

CADTH Reports

CADTH recently completed the following reports:

Environmental Scan

Rapid Response Reports — Drug

Rapid Response Reports — Medical Devices and Systems

Other Tools

Tell Us What You Think

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.